EmergingCo: A Virtual "South-South" Biotech Model.
- Published in:
- Journal of Commercial Biotechnology, 2015, v. 21, n. 4, p. 35, doi. 10.5912/jcb725
- By:
- Publication type:
- Article
Works matching IS 14628732 AND DT 2015 AND VI 21 AND IP 4
Results: 8
1
2
Biosimilars in Brazil: Developments in 2015 and Business Perspectives.
- Published in:
- Journal of Commercial Biotechnology, 2015, v. 21, n. 4, p. 44, doi. 10.5912/jcb724
- By:
- Publication type:
- Article
3
Undermining Patient Values: The ASCO Value in Cancer Care Task Force Framework.
- Published in:
- Journal of Commercial Biotechnology, 2015, v. 21, n. 4, p. 10, doi. 10.5912/jcb723
- By:
- Publication type:
- Article
4
US Supreme Court's Decision on the Patent Ineligibility of Human Genes BRCA1/BRCA2 as Products of Nature.
- Published in:
- Journal of Commercial Biotechnology, 2015, v. 21, n. 4, p. 3, doi. 10.5912/jcb721
- By:
- Publication type:
- Article
5
Investment in Life Sciences in Scotland: Challenges and Opportunities.
- Published in:
- Journal of Commercial Biotechnology, 2015, v. 21, n. 4, p. 29, doi. 10.5912/jcb719
- By:
- Publication type:
- Article
6
The FDA's Quality Revolution.
- Published in:
- Journal of Commercial Biotechnology, 2015, v. 21, n. 4, p. 41, doi. 10.5912/jcb718
- By:
- Publication type:
- Article
7
Crowdfunding: A New Untapped Opportunity for Biotechnology Start-ups?
- Published in:
- Journal of Commercial Biotechnology, 2015, v. 21, n. 4, p. 15, doi. 10.5912/jcb717
- By:
- Publication type:
- Article
8
Flavonoids - World Healthiest Gift for the Benefit of Human Health.
- Published in:
- Journal of Commercial Biotechnology, 2015, v. 21, n. 4, p. 8, doi. 10.5912/jcb716
- By:
- Publication type:
- Article